News

Frost & Sullivan’s 2026 Global Company of the Year

12 May 2026

Frost & Sullivan’s 2026 Global Company of the Year

Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.

  • Reset
Avance Clinical’s CEO Yvonne Lungershausen on Expanding Footprint in Asia-Pacific: A Strategic Focus on South Korea’s Clinical Excellence

7 December 2024

Avance Clinical’s CEO Yvonne Lungershausen on Expanding Footprint in Asia-Pacific: A Strategic Focus on South Korea’s Clinical Excellence

In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical, shared insights into the company’s latest strategic moves in the Asia-Pacific region.

The CEO Magazine – Yvonne Lungershausen

20 November 2024

The CEO Magazine – Yvonne Lungershausen

Under CEO Yvonne Lungershausen’s leadership, Avance Clinical has achieved an exceptional client retention rate, expanded its global biotech client portfolio and boosted revenue by over 500 percent. With a strong focus on innovative, technology-driven research solutions, the company has broadened its international footprint, advancing its mission to deliver improved patient outcomes worldwide.

Avance Clinical Recognized as Finalist in 62nd Australian Export Awards for International Health

18 November 2024

Avance Clinical Recognized as Finalist in 62nd Australian Export Awards for International Health

Avance Clinical, a leading Australian Contract Research Organization (CRO), has been named a finalist in the prestigious 62nd Australian Export Awards, under the International Health category.

Avance Clinical signs MOUs with key Korean trial sites at 2024 KoNECT

30 October 2024

Avance Clinical signs MOUs with key Korean trial sites at 2024 KoNECT

Avance Clinical is proud to announce the signing of three significant Memorandums of Understanding (MOUs) with key Korean clinical sites during KoNECT 2024 conference.

Avance Clinical Welcomes Kelly Yang as Associate Director, Operations Taiwan

15 October 2024

Avance Clinical Welcomes Kelly Yang as Associate Director, Operations Taiwan

Kelly brings over 15 years of experience in the pharmaceutical and clinical research industries, making her a valuable addition to Avance Clinical’s growing team.

Avance Clinical CEO Yvonne Lungershausen Named Finalist for CEO of the Year Award in Healthcare

16 September 2024

Avance Clinical CEO Yvonne Lungershausen Named Finalist for CEO of the Year Award in Healthcare

Avance Clinical is delighted to announce that our CEO, Yvonne Lungershausen, has been named a finalist in The CEO Magazine’s 2024 Executive of the Year Awards in the Healthcare category. This nomination celebrates Yvonne’s exceptional leadership, innovative vision, and her commitment to advancing biotechnology research globally.

Avance Clinical GlobalReady Site Partnership Network Expands Rapidly to 2,000 Site Members

4 September 2024

Avance Clinical GlobalReady Site Partnership Network Expands Rapidly to 2,000 Site Members

Avance Clinical, the award-winning market-leading CRO for biotechs, announced today that 2,000 clinical sites across North America had joined the Avance Clinical GlobalReady Site Partnership Network.

Avance Clinical Wins 2024 Frost & Sullivan Award for Global Biotech CRO Excellence

27 August 2024

Avance Clinical Wins 2024 Frost & Sullivan Award for Global Biotech CRO Excellence

Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence.

Avance Clinical Wins  Premier’s Business and Export Awards 2024

20 August 2024

Avance Clinical Wins Premier’s Business and Export Awards 2024

Avance Clinical is thrilled to announce that it has again been named as a winner in the prestigious South Australian Premier’s Business and Export Awards 2024. This honor underscores Avance Clinical’s continued commitment to driving innovation and delivering world-class clinical trial solutions to the global market, and comes on the heels of winning the 2023 International Health Exporter of the Year at last year’s awards ceremony. 

Avance Clinical Signs MOU with Mid-Ship Biomedical to Strengthen Global Clinical Research Collaboration

12 August 2024

Avance Clinical Signs MOU with Mid-Ship Biomedical to Strengthen Global Clinical Research Collaboration

Avance Clinical Signs MOU with Mid-Ship Biomedical to Strengthen Global Clinical Research Collaboration

Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program

22 July 2024

Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program

Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations based out of the Avance Clinical’s Seoul, Korea office.

Avance Clinical Welcomes  Joe Taouk as Vice President, Global Project Delivery

28 June 2024

Avance Clinical Welcomes Joe Taouk as Vice President, Global Project Delivery

Avance Clinical, a leading Contract Research Organization (CRO) renowned for its innovative solutions in the biotech industry, is excited to announce the appointment of Joe Taouk as Vice President, Global Project Delivery.

Proven industry
experience & expertise

800+

Studies in the past 10 years

500+

Experienced team members

33k+

Participants past 10 years

30

Years of CRO experience